Benefit From Pemigatinib in Cholangiocarcinoma

Nature Reviews Clinical Oncology - United Kingdom
doi 10.1038/s41571-020-0369-z
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy